Trust Board papers November 2012 - Barking Havering and ...
Trust Board papers November 2012 - Barking Havering and ...
Trust Board papers November 2012 - Barking Havering and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PRINCIPAL RISK<br />
What could prevent the objective being<br />
achieved<br />
Risk no, Date on Risk Register<br />
& Risk Scoring:<br />
KEY EXISTING CONTROLS<br />
What controls/systems are in<br />
place to assist in securing delivery<br />
of objective <strong>and</strong> managing<br />
principle risks?<br />
CQC REF:<br />
RESIDUAL RISK<br />
ASSURANCES ON<br />
CONTROLS & IMPACT<br />
Where we gain evidence<br />
that our controls/systems, on<br />
which we are placing<br />
reliance, are effective? The<br />
impact following assurances.<br />
PROGRESS AGAINST<br />
RISKS/ ACTION<br />
PLAN UPDATE<br />
What Actions are undertaken to<br />
mitigate the actual risks?<br />
GAPS IN ASSURANCE<br />
Where we are failing to gain<br />
evidence that our controls /<br />
systems, on which we place<br />
reliance, are effective<br />
GAPS IN<br />
CONTROL<br />
Where are we<br />
failing to put<br />
controls / systems<br />
in place? Where are<br />
we failing in making<br />
them effective?<br />
LEAD<br />
Strategic Objective 5 – To Ensure BHRUT is Financially Secure<br />
Principal Objective: The CIP be delivered fully to the agreed timescales without affecting the quality of care adversely<br />
Risk No: 292 Clinical<br />
Directorates will not<br />
achieve financial target<br />
<strong>and</strong> CIP deliveries<br />
Previous descriptor: <strong>Trust</strong><br />
would not achieve financial<br />
balance<br />
Date on Register: 15.06.2011<br />
Rating Scoring:<br />
Severity:5 x Likelihood:5 = 25<br />
Area: All Clinical<br />
Impact on:<br />
Patient: Poor patient outcome<br />
Staff: none<br />
<strong>Trust</strong>: The <strong>Trust</strong> sustaining<br />
progressive measures<br />
Details updated 24.10.12<br />
**All financial risks will be<br />
reviewed by the newly<br />
appointed Finance Director<br />
8.10.12<br />
- <strong>Trust</strong> has prepared Clinical<br />
Strategy <strong>and</strong> Long-Term<br />
Financial Model (with support<br />
from EY) - reviewed at<br />
October <strong>Trust</strong> <strong>Board</strong>. Model<br />
shows <strong>Trust</strong> reducing but not<br />
eliminating deficit by 2017/18,<br />
although further options are<br />
now being reviewed.<br />
- PMO with support from EY is<br />
developing CIP plans for<br />
2013/14 <strong>and</strong> ensuring full year<br />
benefit from existing schemes<br />
meets <strong>2012</strong>/13 target<br />
4 16<br />
Extreme Red<br />
8.10.12<br />
- Review of Clinical<br />
Strategy, LTFM,<br />
CIP/Transformation<br />
programme by<br />
Transformation <strong>Board</strong>,<br />
Finance Committee,<br />
<strong>Trust</strong> <strong>Board</strong>, NHS<br />
London <strong>and</strong><br />
Commissioners.<br />
Executive sponsorship of<br />
all programmes.<br />
8.10.12<br />
Ongoing work to finalise<br />
clinical strategy <strong>and</strong> LTFM<br />
<strong>and</strong> CIP plan for 2013 /14<br />
8.10.12<br />
- Further options to be<br />
fully developed to<br />
demonstrate financial<br />
viability in the longer<br />
term<br />
- Full year CIP<br />
programme yet to be fully<br />
developed<br />
None identified<br />
following review<br />
David Gilburt Finance Director / Alan Davies Deputy Director of Finance<br />
BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />
14